Page last updated: 2024-09-03

bibw 22 and Experimental Neoplasms

bibw 22 has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bamberger, U; Boven, E; Heckel, A; Jansen, WJ; Kuiper, CM; Lincke, C; Pinedo, HM1
Bamberger, U; Boven, E; Feller, N; Jansen, WJ; Pinedo, HM; van der Wilt, CL1

Other Studies

2 other study(ies) available for bibw 22 and Experimental Neoplasms

ArticleYear
Biochemical modulation of 'classical' multidrug resistance by BIBW22BS, a potent derivative of dipyridamole.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:8

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dipyridamole; Doxorubicin; Drug Resistance, Multiple; Female; Humans; Mice; Mice, Nude; Morpholines; Neoplasm Transplantation; Neoplasms, Experimental; Triamterene; Tumor Cells, Cultured; Vincristine

1994
The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenografts.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Deoxycytidine; Dipyridamole; Doxorubicin; Drug Resistance; Female; Floxuridine; Fluorouracil; Gemcitabine; Humans; Methotrexate; Mice; Mice, Nude; Morpholines; Neoplasms; Neoplasms, Experimental; Protein Binding; Transplantation, Heterologous; Triamterene; Tumor Cells, Cultured; Vincristine

1995